Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
302.00    0.00 (0.00%)
Bid:
302.00
Ask:
302.50
Spread: 0.50 (0.166%)
Market Cap: £178.29m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Disposal

8 May 2018 07:15

RNS Number : 3070N
Treatt PLC
08 May 2018
 

 

 

8 May 2018

 

TREATT PLC

("Treatt" or "the Group")

 

Sale of Earthoil Plantations Limited ("Earthoil Plantations")

 

Treatt, the manufacturer and supplier of innovative ingredient solutions for the flavour, fragrance, beverage and consumer product industries, is pleased to announce the conditional sale of Earthoil Plantations, a wholly owned subsidiary of Treatt, which specialises in the supply of pure, organic, fair trade essential and cold pressed vegetable seed oils for the personal care and cosmetic industries, to Univar Limited (the "Buyer") (the "Sale"). Subject to the satisfaction of certain conditions, the Sale is expected to complete on 31 May 2018 ("Completion").

 

The consideration of £11m (subject to an adjustment based on Earthoil Plantations' actual trading performance in April and May 2018), is receivable in cash in two stages; 90% on Completion and a deferred payment of 10% twelve months after Completion.

 

The Group launched its updated five-year strategic plan in 2017. The new strategic plan, to drive the business through to 2022, is clearly focused on the Group's key product categories of citrus, sugar reduction and tea. Given that strategy, the Board considered personal care ingredients as non-core and this sale is the result of a process undertaken to realise value for the Group.

 

The Sale does not include the Kenyan subsidiaries which will continue to supply Earthoil Plantations under a three-year supply agreement. Transitional services arrangements with Earthoil Plantations have also been agreed for an initial limited period of up to six months from completion.

 

The Group intends to use the proceeds from the Sale to strengthen its balance sheet, and thereby increasing debt capacity for future growth and investment in the Group's key product categories. The Sale is expected to be slightly earnings dilutive for the current financial year ending 30 September 2018.

 

The audited financial results of Earthoil Plantations for the year ended 30 September 2017 showed revenues of £7.7m (2016: £7.9m) and pre-tax profit of £1.18m (2016: £1.05m). The gross assets of Earthoil Plantations were £7.0m as at 31 March 2018.

 

Commenting on the Sale, Group CEO, Daemmon Reeve, said:

 

"As Treatt continues to grow and we embark on our revised 2022 strategy, Earthoil Plantations has become non-core to the Group. This sale will allow us to focus our efforts and resources on developing our business in the global supply of innovative ingredient solutions to the flavour, fragrance, beverage and consumer product industries.

 

May I take this opportunity to thank everyone at Earthoil Plantations for the contribution they have made to Treatt over the past ten years. I am proud to have seen the business develop under Treatt's ownership and wish the company and its employees a bright future under new ownership."

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

Enquiries:

 

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Broker

Investec Investment Banking

Patrick Robb +44 (0)20 7597 5970

David Anderson

Alex Wright

 

Public relations

DRD Partnership

Lawrence Dore +44 (0)20 3865 5971

 

About the Group

Treatt is a global, independent supplier of innovative ingredient solutions for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America, Africa and Asia and has manufacturing facilities in the UK, USA and Kenya. Its international foot print enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

 

For further information about the Group, visit www.treatt.com.

 

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISUGUUGAUPRUQR
Date   Source Headline
10th Feb 20205:29 pmRNSHolding(s) in Company
6th Feb 20209:04 amRNSHolding(s) in Company
5th Feb 20203:53 pmRNSVoting Rights and Capital
31st Jan 20204:54 pmRNSResult of AGM
29th Jan 20205:26 pmRNSDirector/PDMR Shareholding
29th Jan 20205:10 pmRNSHolding(s) in Company
21st Jan 20203:21 pmRNSHolding(s) in Company
21st Jan 20201:26 pmRNSHolding(s) in Company
17th Jan 20203:28 pmRNSDirector/PDMR Shareholding
16th Jan 20205:07 pmRNSHolding(s) in Company
9th Jan 20202:28 pmRNSDirector/PDMR Shareholding - Replacement
8th Jan 20205:04 pmRNSDirector/PDMR Shareholding
7th Jan 20205:16 pmRNSHolding(s) in Company
6th Jan 202011:18 amRNSDirector/PDMR Shareholding
24th Dec 201910:54 amRNSVoting Rights and Capital
18th Dec 20194:03 pmRNSNotification of Transactions of Directors
17th Dec 20194:04 pmRNSDirector/PDMR Shareholding
10th Dec 201912:15 pmRNSAnnual Report
6th Dec 20194:12 pmRNSHolding(s) in Company
2nd Dec 20194:44 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Dec 20194:43 pmRNSBLOCK LISTING SIX MONTHLY RETURN
26th Nov 20197:00 amRNSFinal Results
25th Nov 201912:07 pmRNSSecond Price Monitoring Extn
25th Nov 201912:02 pmRNSPrice Monitoring Extension
22nd Nov 20194:35 pmRNSPrice Monitoring Extension
21st Nov 20193:11 pmRNSBoard Committee Change
6th Nov 20199:44 amRNSHolding(s) in Company
25th Oct 20194:40 pmRNSSecond Price Monitoring Extn
25th Oct 20194:35 pmRNSPrice Monitoring Extension
4th Oct 20197:00 amRNSTrading Update
30th Sep 20194:57 pmRNSNotification of Transaction of a Director
17th Sep 20197:00 amRNSUpdate on Site Relocation
3rd Sep 201912:04 pmRNSDirector/PDMR Shareholding
3rd Sep 201912:01 pmRNSNotification of Transaction of a Director
2nd Sep 20194:55 pmRNSVoting Rights and Capital
21st Aug 201912:07 pmRNSSecond Price Monitoring Extn
21st Aug 201912:02 pmRNSPrice Monitoring Extension
19th Aug 20192:49 pmRNSDirector/PDMR Shareholding
9th Aug 20197:00 amRNSBlock Listing Application
1st Aug 20193:35 pmRNSTotal Voting Rights
25th Jul 201912:07 pmRNSSecond Price Monitoring Extn
25th Jul 201912:02 pmRNSPrice Monitoring Extension
24th Jul 20193:26 pmRNSDirector/PDMR Shareholding
22nd Jul 20194:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20194:35 pmRNSPrice Monitoring Extension
18th Jul 201912:07 pmRNSSecond Price Monitoring Extn
18th Jul 201912:02 pmRNSPrice Monitoring Extension
10th Jul 201912:07 pmRNSSecond Price Monitoring Extn
10th Jul 201912:02 pmRNSPrice Monitoring Extension
8th Jul 201912:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.